Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription

Abstract Prostate cancer is one of the most common cancers in men. This study was conducted to investigate the role of euchromatic histone lysine methyltransferase 2 (EHMT2) and endoplasmic reticulum protein 29 (ERP29) in the progression of radioresistance in prostate cancer. The expression of EHMT2...

Full description

Bibliographic Details
Main Authors: Zhi‐Chao Huang, Jun Huang, Chang‐Kun Huang, Yi Hou, Bin Zhu
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12661
_version_ 1797808853357690880
author Zhi‐Chao Huang
Jun Huang
Chang‐Kun Huang
Yi Hou
Bin Zhu
author_facet Zhi‐Chao Huang
Jun Huang
Chang‐Kun Huang
Yi Hou
Bin Zhu
author_sort Zhi‐Chao Huang
collection DOAJ
description Abstract Prostate cancer is one of the most common cancers in men. This study was conducted to investigate the role of euchromatic histone lysine methyltransferase 2 (EHMT2) and endoplasmic reticulum protein 29 (ERP29) in the progression of radioresistance in prostate cancer. The expression of EHMT2 and ERP29 in prostate cancer cells and during the progression of radioresistance was detected using quantitative reverse transcription‐polymerase chain reaction and western blotting, and the interaction between EHMT2 and ERP29 was investigated. The proliferation of transfected cells under x‐ray irradiation was determined using the methyl thiazolyl tetrazolium and colony formation assays. Flow cytometry was used to analyze the apoptosis of the transfected cells under x‐ray irradiation. Nude mice were subcutaneously injected with prostate cancer (DU145) cells stably transfected with sh‐ERP29 or sh‐NC. The effect of ERP29 expression on radioresistance in nude mice was assessed by x‐ray irradiation. The expression of EHMT2 was upregulated and that of ERP29 was downregulated in prostate cancer cells during radioresistance progression. EHMT2 downregulation suppressed radioresistance in DU145 and androgen‐sensitive prostate cancer (LNCaP) cells. In irradiated DU145 cells, EHMT2 inhibition decreased the number of colonies and accelerated apoptosis. The transcription of ERP29 was suppressed by EHMT2 by upregulating H3K9me2 and downregulating H3K4me3, thereby regulating radioresistance in prostate cancer cells. In addition, the downregulation of ERP29 promoted the progression of radioresistance in prostate cancer cells in nude mice. EHMT2 promotes radioresistance in prostate cancer cells by repressing ERP29 transcription.
first_indexed 2024-03-13T06:43:50Z
format Article
id doaj.art-f4c2d677d0a74c97a7138e62229c5289
institution Directory Open Access Journal
issn 1607-551X
2410-8650
language English
last_indexed 2024-03-13T06:43:50Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series Kaohsiung Journal of Medical Sciences
spelling doaj.art-f4c2d677d0a74c97a7138e62229c52892023-06-08T13:32:18ZengWileyKaohsiung Journal of Medical Sciences1607-551X2410-86502023-06-0139657658610.1002/kjm2.12661Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcriptionZhi‐Chao Huang0Jun Huang1Chang‐Kun Huang2Yi Hou3Bin Zhu4Department of Urology Second Xiangya Hospital, Central South University Changsha Hunan People's Republic of ChinaDepartment of Urology Second Xiangya Hospital, Central South University Changsha Hunan People's Republic of ChinaDepartment of Urology Second Xiangya Hospital, Central South University Changsha Hunan People's Republic of ChinaDepartment of Urology Second Xiangya Hospital, Central South University Changsha Hunan People's Republic of ChinaDepartment of Urology Second Xiangya Hospital, Central South University Changsha Hunan People's Republic of ChinaAbstract Prostate cancer is one of the most common cancers in men. This study was conducted to investigate the role of euchromatic histone lysine methyltransferase 2 (EHMT2) and endoplasmic reticulum protein 29 (ERP29) in the progression of radioresistance in prostate cancer. The expression of EHMT2 and ERP29 in prostate cancer cells and during the progression of radioresistance was detected using quantitative reverse transcription‐polymerase chain reaction and western blotting, and the interaction between EHMT2 and ERP29 was investigated. The proliferation of transfected cells under x‐ray irradiation was determined using the methyl thiazolyl tetrazolium and colony formation assays. Flow cytometry was used to analyze the apoptosis of the transfected cells under x‐ray irradiation. Nude mice were subcutaneously injected with prostate cancer (DU145) cells stably transfected with sh‐ERP29 or sh‐NC. The effect of ERP29 expression on radioresistance in nude mice was assessed by x‐ray irradiation. The expression of EHMT2 was upregulated and that of ERP29 was downregulated in prostate cancer cells during radioresistance progression. EHMT2 downregulation suppressed radioresistance in DU145 and androgen‐sensitive prostate cancer (LNCaP) cells. In irradiated DU145 cells, EHMT2 inhibition decreased the number of colonies and accelerated apoptosis. The transcription of ERP29 was suppressed by EHMT2 by upregulating H3K9me2 and downregulating H3K4me3, thereby regulating radioresistance in prostate cancer cells. In addition, the downregulation of ERP29 promoted the progression of radioresistance in prostate cancer cells in nude mice. EHMT2 promotes radioresistance in prostate cancer cells by repressing ERP29 transcription.https://doi.org/10.1002/kjm2.12661EHMT2ERP29histone methylationprostate cancerradioresistance
spellingShingle Zhi‐Chao Huang
Jun Huang
Chang‐Kun Huang
Yi Hou
Bin Zhu
Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
Kaohsiung Journal of Medical Sciences
EHMT2
ERP29
histone methylation
prostate cancer
radioresistance
title Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
title_full Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
title_fullStr Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
title_full_unstemmed Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
title_short Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
title_sort euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription
topic EHMT2
ERP29
histone methylation
prostate cancer
radioresistance
url https://doi.org/10.1002/kjm2.12661
work_keys_str_mv AT zhichaohuang euchromatichistonelysinemethyltransferase2facilitatesradioresistanceinprostatecancerbyrepressingendoplasmicreticulumprotein29transcription
AT junhuang euchromatichistonelysinemethyltransferase2facilitatesradioresistanceinprostatecancerbyrepressingendoplasmicreticulumprotein29transcription
AT changkunhuang euchromatichistonelysinemethyltransferase2facilitatesradioresistanceinprostatecancerbyrepressingendoplasmicreticulumprotein29transcription
AT yihou euchromatichistonelysinemethyltransferase2facilitatesradioresistanceinprostatecancerbyrepressingendoplasmicreticulumprotein29transcription
AT binzhu euchromatichistonelysinemethyltransferase2facilitatesradioresistanceinprostatecancerbyrepressingendoplasmicreticulumprotein29transcription